nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—ABHD12—optic choroid—ocular cancer	0.167	0.64	CbGeAlD
Orlistat—ABHD12—eye—ocular cancer	0.0337	0.129	CbGeAlD
Orlistat—ABHD12—retina—ocular cancer	0.0334	0.128	CbGeAlD
Orlistat—PLA2G7—lymphoid tissue—ocular cancer	0.027	0.103	CbGeAlD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—ocular cancer	0.0113	0.0153	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.0111	0.015	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.0111	0.015	CbGpPWpGaD
Orlistat—FASN—Integration of energy metabolism—GNAQ—ocular cancer	0.011	0.0149	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—RPL39—ocular cancer	0.0106	0.0143	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—ocular cancer	0.0105	0.0142	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—ocular cancer	0.0105	0.0142	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.0103	0.0139	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.0103	0.0139	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—MDM2—ocular cancer	0.00932	0.0126	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—CDK2—ocular cancer	0.00878	0.0119	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—GNA11—ocular cancer	0.0076	0.0103	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—RB1—ocular cancer	0.00722	0.00977	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—GNAQ—ocular cancer	0.00706	0.00956	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—MDM2—ocular cancer	0.00615	0.00833	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PSPH—ocular cancer	0.00609	0.00824	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—CDKN1A—ocular cancer	0.00578	0.00782	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00571	0.00773	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—GNA11—ocular cancer	0.0057	0.00772	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—GNA11—ocular cancer	0.0057	0.00772	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0056	0.00758	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—GNAQ—ocular cancer	0.0053	0.00718	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—GNAQ—ocular cancer	0.0053	0.00718	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—CDKN1A—ocular cancer	0.00519	0.00702	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—EP300—ocular cancer	0.00493	0.00668	CbGpPWpGaD
Orlistat—PNLIP—Disease—SAG—ocular cancer	0.00482	0.00652	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HDAC1—ocular cancer	0.00478	0.00647	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—HDAC1—ocular cancer	0.00478	0.00647	CbGpPWpGaD
Orlistat—FASN—Metabolism—PSPH—ocular cancer	0.00431	0.00583	CbGpPWpGaD
Orlistat—FASN—p73 transcription factor network—MYC—ocular cancer	0.0043	0.00582	CbGpPWpGaD
Orlistat—PNLIP—Disease—E2F5—ocular cancer	0.00426	0.00577	CbGpPWpGaD
Orlistat—PNLIP—Disease—E2F4—ocular cancer	0.00417	0.00565	CbGpPWpGaD
Orlistat—PNLIP—Disease—RBL1—ocular cancer	0.00409	0.00554	CbGpPWpGaD
Orlistat—PNLIP—Disease—RPL39—ocular cancer	0.00409	0.00554	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SAG—ocular cancer	0.00407	0.00551	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SAG—ocular cancer	0.00407	0.00551	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—TP53—ocular cancer	0.00393	0.00533	CbGpPWpGaD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—MYC—ocular cancer	0.00362	0.0049	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—GNA11—ocular cancer	0.0036	0.00488	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—GNA11—ocular cancer	0.0036	0.00488	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—E2F5—ocular cancer	0.0036	0.00488	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—E2F5—ocular cancer	0.0036	0.00488	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—E2F4—ocular cancer	0.00353	0.00478	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—E2F4—ocular cancer	0.00353	0.00478	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—RBL1—ocular cancer	0.00346	0.00468	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—RBL1—ocular cancer	0.00346	0.00468	CbGpPWpGaD
Orlistat—FASN—Disease—SAG—ocular cancer	0.00341	0.00461	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—CDK2—ocular cancer	0.00339	0.00459	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—CDK2—ocular cancer	0.00339	0.00459	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SAG—ocular cancer	0.00337	0.00457	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—GNAQ—ocular cancer	0.00335	0.00454	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—GNAQ—ocular cancer	0.00335	0.00454	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—AKT1—ocular cancer	0.00332	0.0045	CbGpPWpGaD
Orlistat—FASN—SREBP signalling—AKT1—ocular cancer	0.00332	0.0045	CbGpPWpGaD
Orlistat—PNLIP—Disease—TFDP1—ocular cancer	0.0033	0.00447	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—GNA11—ocular cancer	0.00327	0.00443	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—GNA11—ocular cancer	0.00327	0.00443	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00321	0.00435	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00321	0.00435	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—GNAQ—ocular cancer	0.00304	0.00412	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—GNAQ—ocular cancer	0.00304	0.00412	CbGpPWpGaD
Orlistat—FASN—Disease—E2F5—ocular cancer	0.00301	0.00408	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—E2F3—ocular cancer	0.003	0.00406	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—E2F3—ocular cancer	0.003	0.00406	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—E2F5—ocular cancer	0.00298	0.00404	CbGpPWpGaD
Orlistat—FASN—Disease—E2F4—ocular cancer	0.00295	0.004	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—E2F4—ocular cancer	0.00292	0.00396	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00291	0.00393	CbGpPWpGaD
Orlistat—FASN—Disease—RPL39—ocular cancer	0.0029	0.00392	CbGpPWpGaD
Orlistat—FASN—Disease—RBL1—ocular cancer	0.0029	0.00392	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—RBL1—ocular cancer	0.00287	0.00388	CbGpPWpGaD
Orlistat—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—ocular cancer	0.00284	0.00385	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TFDP1—ocular cancer	0.00279	0.00378	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TFDP1—ocular cancer	0.00279	0.00378	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00278	0.00377	CbGpPWpGaD
Orlistat—PNLIP—Disease—MAML2—ocular cancer	0.00262	0.00355	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00259	0.0035	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00259	0.0035	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00259	0.0035	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.00255	0.00346	CbGpPWpGaD
Orlistat—PLA2G4A—PDGF Pathway—HRAS—ocular cancer	0.00255	0.00345	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—E2F3—ocular cancer	0.00249	0.00337	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00235	0.00318	CbGpPWpGaD
Orlistat—FASN—Disease—TFDP1—ocular cancer	0.00233	0.00316	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TFDP1—ocular cancer	0.00231	0.00313	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00223	0.00302	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00223	0.00302	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MAML2—ocular cancer	0.00222	0.003	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MAML2—ocular cancer	0.00222	0.003	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00216	0.00292	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GNA11—ocular cancer	0.00193	0.00262	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GNA11—ocular cancer	0.00193	0.00262	CbGpPWpGaD
Orlistat—PNLIP—Disease—HDAC1—ocular cancer	0.00192	0.0026	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GNA11—ocular cancer	0.00192	0.00259	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—EP300—ocular cancer	0.00191	0.00258	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—EP300—ocular cancer	0.00191	0.00258	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00186	0.00252	CbGpPWpGaD
Orlistat—FASN—Disease—MAML2—ocular cancer	0.00185	0.00251	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PSPH—ocular cancer	0.00185	0.0025	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MAML2—ocular cancer	0.00184	0.00249	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—GNAQ—ocular cancer	0.0018	0.00243	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—GNAQ—ocular cancer	0.0018	0.00243	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	0.00178	0.00241	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GNAQ—ocular cancer	0.00178	0.00241	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00176	0.00238	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—HRAS—ocular cancer	0.00174	0.00235	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN2B—ocular cancer	0.00172	0.00233	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TGFB1—ocular cancer	0.00166	0.00224	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—ocular cancer	0.00166	0.00224	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HDAC1—ocular cancer	0.00162	0.00219	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HDAC1—ocular cancer	0.00162	0.00219	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GNA11—ocular cancer	0.0016	0.00217	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.00157	0.00213	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—AKT1—ocular cancer	0.00153	0.00208	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—GNAQ—ocular cancer	0.00149	0.00202	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—AKT1—ocular cancer	0.00148	0.002	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN2B—ocular cancer	0.00145	0.00197	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN2B—ocular cancer	0.00145	0.00197	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00144	0.00195	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—GNA11—ocular cancer	0.00143	0.00194	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TP53—ocular cancer	0.00136	0.00185	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TP53—ocular cancer	0.00136	0.00185	CbGpPWpGaD
Orlistat—FASN—Disease—HDAC1—ocular cancer	0.00136	0.00184	CbGpPWpGaD
Orlistat—FASN—Metabolism—GNA11—ocular cancer	0.00136	0.00184	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HDAC1—ocular cancer	0.00134	0.00182	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—GNAQ—ocular cancer	0.00133	0.00181	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—E2F1—ocular cancer	0.00133	0.0018	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—E2F1—ocular cancer	0.00133	0.0018	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—HRAS—ocular cancer	0.0013	0.00177	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HRAS—ocular cancer	0.0013	0.00177	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.0013	0.00176	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—MYC—ocular cancer	0.00128	0.00173	CbGpPWpGaD
Orlistat—FASN—Metabolism—GNAQ—ocular cancer	0.00126	0.00171	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN2B—ocular cancer	0.00122	0.00165	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN2B—ocular cancer	0.0012	0.00163	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HDAC1—ocular cancer	0.0012	0.00163	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00119	0.00161	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—AKT1—ocular cancer	0.00115	0.00156	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—AKT1—ocular cancer	0.00115	0.00156	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00114	0.00154	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—E2F1—ocular cancer	0.0011	0.0015	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.0011	0.00149	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00104	0.00141	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SAG—ocular cancer	0.00102	0.00139	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00102	0.00138	CbGpPWpGaD
Orlistat—PLA2G4A—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.001	0.00136	CbGpPWpGaD
Orlistat—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000953	0.00129	CbGpPWpGaD
Orlistat—PNLIP—Disease—MDM2—ocular cancer	0.000953	0.00129	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000911	0.00123	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000908	0.00123	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—E2F5—ocular cancer	0.000906	0.00123	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—E2F4—ocular cancer	0.000888	0.0012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—RBL1—ocular cancer	0.00087	0.00118	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN1B—ocular cancer	0.00087	0.00118	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—CDK2—ocular cancer	0.000853	0.00116	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GNA11—ocular cancer	0.000823	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000808	0.00109	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MDM2—ocular cancer	0.000806	0.00109	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MDM2—ocular cancer	0.000806	0.00109	CbGpPWpGaD
Orlistat—PNLIP—Disease—CDKN1A—ocular cancer	0.000803	0.00109	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—GNAQ—ocular cancer	0.000765	0.00104	CbGpPWpGaD
Orlistat—PNLIP—Disease—EP300—ocular cancer	0.000764	0.00103	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—E2F3—ocular cancer	0.000755	0.00102	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HRAS—ocular cancer	0.000748	0.00101	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HRAS—ocular cancer	0.000748	0.00101	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000748	0.00101	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1B—ocular cancer	0.000736	0.000996	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1B—ocular cancer	0.000736	0.000996	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AKT1—ocular cancer	0.000728	0.000985	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AKT1—ocular cancer	0.000728	0.000985	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCND1—ocular cancer	0.000702	0.00095	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TFDP1—ocular cancer	0.000702	0.00095	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCND1—ocular cancer	0.000702	0.00095	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CDKN1A—ocular cancer	0.000679	0.000919	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CDKN1A—ocular cancer	0.000679	0.000919	CbGpPWpGaD
Orlistat—FASN—Disease—MDM2—ocular cancer	0.000674	0.000913	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MDM2—ocular cancer	0.000667	0.000904	CbGpPWpGaD
Orlistat—PNLIP—Disease—MYC—ocular cancer	0.000666	0.000902	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—ocular cancer	0.000664	0.000899	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AKT1—ocular cancer	0.000661	0.000894	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AKT1—ocular cancer	0.000661	0.000894	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EP300—ocular cancer	0.000646	0.000874	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EP300—ocular cancer	0.000646	0.000874	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EP300—ocular cancer	0.00064	0.000867	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000631	0.000855	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1B—ocular cancer	0.000616	0.000834	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1B—ocular cancer	0.000609	0.000825	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GNA11—ocular cancer	0.000582	0.000787	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CCND1—ocular cancer	0.000581	0.000787	CbGpPWpGaD
Orlistat—FASN—Disease—CDKN1A—ocular cancer	0.000568	0.000769	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MYC—ocular cancer	0.000563	0.000762	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MYC—ocular cancer	0.000563	0.000762	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CDKN1A—ocular cancer	0.000562	0.000761	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000562	0.000761	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—ocular cancer	0.000561	0.00076	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—ocular cancer	0.000561	0.00076	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MAML2—ocular cancer	0.000557	0.000755	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GNAQ—ocular cancer	0.000541	0.000732	CbGpPWpGaD
Orlistat—FASN—Disease—EP300—ocular cancer	0.000541	0.000732	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EP300—ocular cancer	0.000535	0.000725	CbGpPWpGaD
Orlistat—PNLIP—Disease—HRAS—ocular cancer	0.000523	0.000708	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GNA11—ocular cancer	0.000486	0.000658	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EP300—ocular cancer	0.000479	0.000649	CbGpPWpGaD
Orlistat—FASN—Disease—MYC—ocular cancer	0.000471	0.000638	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—ocular cancer	0.00047	0.000636	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MYC—ocular cancer	0.000466	0.000631	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—ocular cancer	0.000465	0.00063	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TP53—ocular cancer	0.000462	0.000626	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TP53—ocular cancer	0.000462	0.000626	CbGpPWpGaD
Orlistat—PNLIP—Disease—AKT1—ocular cancer	0.000462	0.000625	CbGpPWpGaD
Orlistat—FASN—Metabolism—EP300—ocular cancer	0.000453	0.000613	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—GNAQ—ocular cancer	0.000452	0.000612	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HRAS—ocular cancer	0.000442	0.000598	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HRAS—ocular cancer	0.000442	0.000598	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000436	0.000591	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PSPH—ocular cancer	0.000433	0.000586	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—ocular cancer	0.000417	0.000564	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HDAC1—ocular cancer	0.000408	0.000552	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AKT1—ocular cancer	0.00039	0.000528	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AKT1—ocular cancer	0.00039	0.000528	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—AKT1—ocular cancer	0.000387	0.000524	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TP53—ocular cancer	0.000383	0.000519	CbGpPWpGaD
Orlistat—FASN—Disease—HRAS—ocular cancer	0.00037	0.000501	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HRAS—ocular cancer	0.000366	0.000496	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN2B—ocular cancer	0.000365	0.000495	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TP53—ocular cancer	0.000343	0.000464	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—E2F1—ocular cancer	0.000335	0.000454	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HRAS—ocular cancer	0.000328	0.000444	CbGpPWpGaD
Orlistat—FASN—Disease—AKT1—ocular cancer	0.000327	0.000442	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AKT1—ocular cancer	0.000323	0.000438	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—AKT1—ocular cancer	0.00029	0.000392	CbGpPWpGaD
Orlistat—FASN—Metabolism—AKT1—ocular cancer	0.000274	0.00037	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MDM2—ocular cancer	0.000203	0.000274	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EP300—ocular cancer	0.000194	0.000263	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HRAS—ocular cancer	0.000188	0.000255	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1B—ocular cancer	0.000185	0.000251	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCND1—ocular cancer	0.000177	0.000239	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CDKN1A—ocular cancer	0.000171	0.000231	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AKT1—ocular cancer	0.000166	0.000225	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EP300—ocular cancer	0.000162	0.00022	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MYC—ocular cancer	0.000142	0.000192	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—ocular cancer	0.000141	0.000191	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GNA11—ocular cancer	0.000136	0.000184	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000127	0.000171	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—AKT1—ocular cancer	0.000117	0.000159	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TP53—ocular cancer	0.000116	0.000157	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HRAS—ocular cancer	0.000111	0.000151	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AKT1—ocular cancer	9.82e-05	0.000133	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EP300—ocular cancer	4.55e-05	6.16e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—AKT1—ocular cancer	2.75e-05	3.72e-05	CbGpPWpGaD
